Search Within

Michael Forman Berger

Formats
  1. Meeting Abstract (426)
  2. Journal Article (327)
  3. Research Letter (9)
  4. Editorial (3)
  5. Guidelines (2)
  6. Review (2)
  7. Book Section (1)
  8. Conference Paper (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (771)
  2. Department of Pathology and Laboratory Medicine (771)
  3. GSK Faculty (771)
  4. Human Oncology and Pathogenesis Program (771)
  5. Department of Medicine (612)
  6. Solid Tumor Oncology Division (583)

More Groups

People
  1. David Solit (316)
  2. Marc Ladanyi (220)
  3. Ahmet Zehir (191)
  4. Maria Arcila (163)
  5. Nikolaus Schultz (157)
  6. Hikmat Al-Ahmadie (108)

More People

Years
  1. 2025 (21)
  2. 2024 (47)
  3. 2023 (55)
  4. 2022 (56)
  5. 2021 (40)
  6. 2020 (47)

More Years

Publications
  1. Journal of Clinical Oncology (156)
  2. Cancer Research (67)
  3. Modern Pathology (65)
  4. Clinical Cancer Research (53)
  5. Laboratory Investigation (52)
  6. Journal of Molecular Diagnostics (38)

More Publications

Publishers
  1. American Society of Clinical Oncology (178)
  2. American Association for Cancer Research (146)
  3. Nature Publishing Group (111)
  4. Nature Research (68)
  5. Elsevier Science, Inc. (46)
  6. Oxford University Press (39)

More Publishers

Results (771)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of ERBB2 extrachromosomal DNA (ecDNA) with first-line HER2-targeted treatment outcomes in advanced esophagogastric adenocarcinoma (EGC)
    Meeting Abstract

    Tsai, C.; Suman, S.; Chu, C.; Chou, J. F.; Krein, P. M.; Capanu, M.; Ilson, D. H.; Ku, G. Y.; Janjigian, Y. Y.; Drilon, A. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Genomic landscape of MTAP deletions and association with EGFR alterations in NSCLC
    Meeting Abstract

    Thummalapalli, R.; Muldoon, D.; Febres-Aldana, C. A.; Falcon, C. J.; Pupo, A.; Bandlamudi, C.; Berger, M. F.; Yu, H. A.; Riely, G. J.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Tracking the FDA precision oncology drug approval landscape in OncoKB
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Zhang, H.; Nissan, M. H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Nandakumar, S.; Arcila, M. E.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Serial cell-free DNA sequencing in ROS1 fusion-positive lung cancers during treatment with entrectinib
    Journal Article

    Choudhury, N. J.; Woo, H. J.; Chen, M.; Shah, R.; Donoghue, M.; Berger, M.; Drilon, A.
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Early on-treatment assessment of T cells, cytokines, and tumor DNA with adaptively dosed nivolumab + ipilimumab: Final results from the phase 2 ADAPT-IT study
    Journal Article

    Smithy, J. W.; Kalvin, H. L.; Ehrich, F. D.; Shah, R.; Adamow, M.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment
    Journal Article

    Widman, A. J.; Shah, M.; Frydendahl, A.; Halmos, D.; Khamnei, C. C.; Øgaard, N.; Rajagopalan, S.; Arora, A.; Deshpande, A.; Hooper, W. F.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • Deep-learning model for tumor-type prediction using targeted clinical genomic sequencing data
    Journal Article

    Darmofal, M.; Suman, S.; Atwal, G.; Toomey, M.; Chen, J. F.; Chang, J. C.; Vakiani, E.; Varghese, A. M.; Balakrishnan Rema, A.; Syed, A.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • ERBB2 alterations in non-muscle invasive bladder cancer are associated with a distinct genomic signature
    Meeting Abstract

    Alam, S. M.; Tallman, J.; Koll, F.; D'Souza, N.; de Jesus Escano, M.; Donahue, T.; Goh, A.; Sarungbam, J.; Berger, M.; Schultz, N.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Genomic characterization of high-grade Ta urothelial carcinoma with and without carcinoma in situ
    Meeting Abstract

    Tallman, J. E.; Alam, S. M.; Koll, F.; Baky, F. J.; D'Souza, N.; de Jesus Escano, M.; Donahue, T. F.; Goh, A. C.; Sarungbam, J.; Berger, M. F.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save